Table of Content

1 Coronary Intervention Drug Eluting Stent Market Overview
1.1 Product Overview and Scope of Coronary Intervention Drug Eluting Stent
1.2 Coronary Intervention Drug Eluting Stent Segment by Type
1.2.1 Global Coronary Intervention Drug Eluting Stent Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Below 40 µm
1.2.3 40 µm- 65 µm
1.2.4 Above 65 µm
1.3 Coronary Intervention Drug Eluting Stent Segment by Application
1.3.1 Coronary Intervention Drug Eluting Stent Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Coronary Intervention Drug Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Coronary Intervention Drug Eluting Stent Revenue 2016-2027
1.4.2 Global Coronary Intervention Drug Eluting Stent Sales 2016-2027
1.4.3 Coronary Intervention Drug Eluting Stent Market Size by Region: 2016 Versus 2021 Versus 2027

2 Coronary Intervention Drug Eluting Stent Market Competition by Manufacturers
2.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Manufacturers (2016-2021)
2.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Coronary Intervention Drug Eluting Stent Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Coronary Intervention Drug Eluting Stent Manufacturing Sites, Area Served, Product Type
2.5 Coronary Intervention Drug Eluting Stent Market Competitive Situation and Trends
2.5.1 Coronary Intervention Drug Eluting Stent Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Coronary Intervention Drug Eluting Stent Players Market Share by Revenue
2.5.3 Global Coronary Intervention Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Coronary Intervention Drug Eluting Stent Retrospective Market Scenario by Region
3.1 Global Coronary Intervention Drug Eluting Stent Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Coronary Intervention Drug Eluting Stent Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
3.3.1 North America Coronary Intervention Drug Eluting Stent Sales by Country
3.3.2 North America Coronary Intervention Drug Eluting Stent Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
3.4.1 Europe Coronary Intervention Drug Eluting Stent Sales by Country
3.4.2 Europe Coronary Intervention Drug Eluting Stent Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Coronary Intervention Drug Eluting Stent Market Facts & Figures by Region
3.5.1 Asia Pacific Coronary Intervention Drug Eluting Stent Sales by Region
3.5.2 Asia Pacific Coronary Intervention Drug Eluting Stent Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
3.6.1 Latin America Coronary Intervention Drug Eluting Stent Sales by Country
3.6.2 Latin America Coronary Intervention Drug Eluting Stent Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
3.7.1 Middle East and Africa Coronary Intervention Drug Eluting Stent Sales by Country
3.7.2 Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Coronary Intervention Drug Eluting Stent Historic Market Analysis by Type
4.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
4.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2016-2021)
4.3 Global Coronary Intervention Drug Eluting Stent Price by Type (2016-2021)

5 Global Coronary Intervention Drug Eluting Stent Historic Market Analysis by Application
5.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
5.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application (2016-2021)
5.3 Global Coronary Intervention Drug Eluting Stent Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Synlas GmbH
6.1.1 Synlas GmbH Corporation Information
6.1.2 Synlas GmbH Description and Business Overview
6.1.3 Synlas GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Synlas GmbH Product Portfolio
6.1.5 Synlas GmbH Recent Developments/Updates
6.2 YILSON
6.2.1 YILSON Corporation Information
6.2.2 YILSON Description and Business Overview
6.2.3 YILSON Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.2.4 YILSON Product Portfolio
6.2.5 YILSON Recent Developments/Updates
6.3 BrosMed Medical
6.3.1 BrosMed Medical Corporation Information
6.3.2 BrosMed Medical Description and Business Overview
6.3.3 BrosMed Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.3.4 BrosMed Medical Product Portfolio
6.3.5 BrosMed Medical Recent Developments/Updates
6.4 SCITECH Medical
6.4.1 SCITECH Medical Corporation Information
6.4.2 SCITECH Medical Description and Business Overview
6.4.3 SCITECH Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.4.4 SCITECH Medical Product Portfolio
6.4.5 SCITECH Medical Recent Developments/Updates
6.5 Wellinq
6.5.1 Wellinq Corporation Information
6.5.2 Wellinq Description and Business Overview
6.5.3 Wellinq Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Wellinq Product Portfolio
6.5.5 Wellinq Recent Developments/Updates
6.6 Degania Silicone
6.6.1 Degania Silicone Corporation Information
6.6.2 Degania Silicone Description and Business Overview
6.6.3 Degania Silicone Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Degania Silicone Product Portfolio
6.6.5 Degania Silicone Recent Developments/Updates
6.7 Alvimedica
6.6.1 Alvimedica Corporation Information
6.6.2 Alvimedica Description and Business Overview
6.6.3 Alvimedica Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Alvimedica Product Portfolio
6.7.5 Alvimedica Recent Developments/Updates
6.8 Interventional Medical Device Solutions
6.8.1 Interventional Medical Device Solutions Corporation Information
6.8.2 Interventional Medical Device Solutions Description and Business Overview
6.8.3 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Interventional Medical Device Solutions Product Portfolio
6.8.5 Interventional Medical Device Solutions Recent Developments/Updates
6.9 Comed BV
6.9.1 Comed BV Corporation Information
6.9.2 Comed BV Description and Business Overview
6.9.3 Comed BV Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Comed BV Product Portfolio
6.9.5 Comed BV Recent Developments/Updates
6.10 iVascular
6.10.1 iVascular Corporation Information
6.10.2 iVascular Description and Business Overview
6.10.3 iVascular Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.10.4 iVascular Product Portfolio
6.10.5 iVascular Recent Developments/Updates
6.11 LEPU Medical
6.11.1 LEPU Medical Corporation Information
6.11.2 LEPU Medical Coronary Intervention Drug Eluting Stent Description and Business Overview
6.11.3 LEPU Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.11.4 LEPU Medical Product Portfolio
6.11.5 LEPU Medical Recent Developments/Updates
6.12 Eurocor Tech GmbH
6.12.1 Eurocor Tech GmbH Corporation Information
6.12.2 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Description and Business Overview
6.12.3 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Eurocor Tech GmbH Product Portfolio
6.12.5 Eurocor Tech GmbH Recent Developments/Updates
6.13 OrbusNeich
6.13.1 OrbusNeich Corporation Information
6.13.2 OrbusNeich Coronary Intervention Drug Eluting Stent Description and Business Overview
6.13.3 OrbusNeich Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.13.4 OrbusNeich Product Portfolio
6.13.5 OrbusNeich Recent Developments/Updates
6.14 Endocor GmbH
6.14.1 Endocor GmbH Corporation Information
6.14.2 Endocor GmbH Coronary Intervention Drug Eluting Stent Description and Business Overview
6.14.3 Endocor GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Endocor GmbH Product Portfolio
6.14.5 Endocor GmbH Recent Developments/Updates
6.15 Meril Life Sciences
6.15.1 Meril Life Sciences Corporation Information
6.15.2 Meril Life Sciences Coronary Intervention Drug Eluting Stent Description and Business Overview
6.15.3 Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Meril Life Sciences Product Portfolio
6.15.5 Meril Life Sciences Recent Developments/Updates
6.16 Acrostak
6.16.1 Acrostak Corporation Information
6.16.2 Acrostak Coronary Intervention Drug Eluting Stent Description and Business Overview
6.16.3 Acrostak Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Acrostak Product Portfolio
6.16.5 Acrostak Recent Developments/Updates
6.17 Boston Scientific Corporation
6.17.1 Boston Scientific Corporation Corporation Information
6.17.2 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Description and Business Overview
6.17.3 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Boston Scientific Corporation Product Portfolio
6.17.5 Boston Scientific Corporation Recent Developments/Updates
6.18 B. Braun
6.18.1 B. Braun Corporation Information
6.18.2 B. Braun Coronary Intervention Drug Eluting Stent Description and Business Overview
6.18.3 B. Braun Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.18.4 B. Braun Product Portfolio
6.18.5 B. Braun Recent Developments/Updates
6.19 Biotronik
6.19.1 Biotronik Corporation Information
6.19.2 Biotronik Coronary Intervention Drug Eluting Stent Description and Business Overview
6.19.3 Biotronik Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Biotronik Product Portfolio
6.19.5 Biotronik Recent Developments/Updates
6.20 Abbott
6.20.1 Abbott Corporation Information
6.20.2 Abbott Coronary Intervention Drug Eluting Stent Description and Business Overview
6.20.3 Abbott Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Abbott Product Portfolio
6.20.5 Abbott Recent Developments/Updates
6.21 MicroPort Medical Group
6.21.1 MicroPort Medical Group Corporation Information
6.21.2 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Description and Business Overview
6.21.3 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.21.4 MicroPort Medical Group Product Portfolio
6.21.5 MicroPort Medical Group Recent Developments/Updates
6.22 Philips
6.22.1 Philips Corporation Information
6.22.2 Philips Coronary Intervention Drug Eluting Stent Description and Business Overview
6.22.3 Philips Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Philips Product Portfolio
6.22.5 Philips Recent Developments/Updates
6.23 Terumo Corporation
6.23.1 Terumo Corporation Corporation Information
6.23.2 Terumo Corporation Coronary Intervention Drug Eluting Stent Description and Business Overview
6.23.3 Terumo Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Terumo Corporation Product Portfolio
6.23.5 Terumo Corporation Recent Developments/Updates

7 Coronary Intervention Drug Eluting Stent Manufacturing Cost Analysis
7.1 Coronary Intervention Drug Eluting Stent Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Coronary Intervention Drug Eluting Stent
7.4 Coronary Intervention Drug Eluting Stent Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Coronary Intervention Drug Eluting Stent Distributors List
8.3 Coronary Intervention Drug Eluting Stent Customers

9 Coronary Intervention Drug Eluting Stent Market Dynamics
9.1 Coronary Intervention Drug Eluting Stent Industry Trends
9.2 Coronary Intervention Drug Eluting Stent Growth Drivers
9.3 Coronary Intervention Drug Eluting Stent Market Challenges
9.4 Coronary Intervention Drug Eluting Stent Market Restraints

10 Global Market Forecast
10.1 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Type (2022-2027)
10.2 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Application (2022-2027)
10.3 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Coronary Intervention Drug Eluting Stent Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Coronary Intervention Drug Eluting Stent Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Coronary Intervention Drug Eluting Stent Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Coronary Intervention Drug Eluting Stent Covered in This Study
Table 5. Global Coronary Intervention Drug Eluting Stent Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Coronary Intervention Drug Eluting Stent Sales Share by Manufacturers (2016-2021)
Table 7. Global Coronary Intervention Drug Eluting Stent Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Coronary Intervention Drug Eluting Stent Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Coronary Intervention Drug Eluting Stent Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Coronary Intervention Drug Eluting Stent Manufacturing Sites and Area Served
Table 11. Manufacturers Coronary Intervention Drug Eluting Stent Product Type
Table 12. Global Coronary Intervention Drug Eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Coronary Intervention Drug Eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coronary Intervention Drug Eluting Stent as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Coronary Intervention Drug Eluting Stent Sales by Region (2016-2021) & (K Units)
Table 16. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2016-2021)
Table 17. Global Coronary Intervention Drug Eluting Stent Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 19. North America Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)
Table 20. North America Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)
Table 22. Europe Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 23. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)
Table 24. Europe Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Coronary Intervention Drug Eluting Stent Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Coronary Intervention Drug Eluting Stent Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Coronary Intervention Drug Eluting Stent Revenue Market Share by Region (2016-2021)
Table 30. Latin America Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)
Table 32. Latin America Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)
Table 38. Global Coronary Intervention Drug Eluting Stent Sales (K Units) by Type (2016-2021)
Table 39. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
Table 40. Global Coronary Intervention Drug Eluting Stent Revenue (Million US$) by Type (2016-2021)
Table 41. Global Coronary Intervention Drug Eluting Stent Revenue Share by Type (2016-2021)
Table 42. Global Coronary Intervention Drug Eluting Stent Price (US$/Unit) by Type (2016-2021)
Table 43. Global Coronary Intervention Drug Eluting Stent Sales (K Units) by Application (2016-2021)
Table 44. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
Table 45. Global Coronary Intervention Drug Eluting Stent Revenue (Million US$) by Application (2016-2021)
Table 46. Global Coronary Intervention Drug Eluting Stent Revenue Share by Application (2016-2021)
Table 47. Global Coronary Intervention Drug Eluting Stent Price (US$/Unit) by Application (2016-2021)
Table 48. Synlas GmbH Corporation Information
Table 49. Synlas GmbH Description and Business Overview
Table 50. Synlas GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Synlas GmbH Coronary Intervention Drug Eluting Stent Product
Table 52. Synlas GmbH Recent Developments/Updates
Table 53. YILSON Corporation Information
Table 54. YILSON Description and Business Overview
Table 55. YILSON Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. YILSON Coronary Intervention Drug Eluting Stent Product
Table 57. YILSON Recent Developments/Updates
Table 58. BrosMed Medical Corporation Information
Table 59. BrosMed Medical Description and Business Overview
Table 60. BrosMed Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. BrosMed Medical Coronary Intervention Drug Eluting Stent Product
Table 62. BrosMed Medical Recent Developments/Updates
Table 63. SCITECH Medical Corporation Information
Table 64. SCITECH Medical Description and Business Overview
Table 65. SCITECH Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. SCITECH Medical Coronary Intervention Drug Eluting Stent Product
Table 67. SCITECH Medical Recent Developments/Updates
Table 68. Wellinq Corporation Information
Table 69. Wellinq Description and Business Overview
Table 70. Wellinq Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Wellinq Coronary Intervention Drug Eluting Stent Product
Table 72. Wellinq Recent Developments/Updates
Table 73. Degania Silicone Corporation Information
Table 74. Degania Silicone Description and Business Overview
Table 75. Degania Silicone Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Degania Silicone Coronary Intervention Drug Eluting Stent Product
Table 77. Degania Silicone Recent Developments/Updates
Table 78. Alvimedica Corporation Information
Table 79. Alvimedica Description and Business Overview
Table 80. Alvimedica Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Alvimedica Coronary Intervention Drug Eluting Stent Product
Table 82. Alvimedica Recent Developments/Updates
Table 83. Interventional Medical Device Solutions Corporation Information
Table 84. Interventional Medical Device Solutions Description and Business Overview
Table 85. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product
Table 87. Interventional Medical Device Solutions Recent Developments/Updates
Table 88. Comed BV Corporation Information
Table 89. Comed BV Description and Business Overview
Table 90. Comed BV Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Comed BV Coronary Intervention Drug Eluting Stent Product
Table 92. Comed BV Recent Developments/Updates
Table 93. iVascular Corporation Information
Table 94. iVascular Description and Business Overview
Table 95. iVascular Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. iVascular Coronary Intervention Drug Eluting Stent Product
Table 97. iVascular Recent Developments/Updates
Table 98. LEPU Medical Corporation Information
Table 99. LEPU Medical Description and Business Overview
Table 100. LEPU Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. LEPU Medical Coronary Intervention Drug Eluting Stent Product
Table 102. LEPU Medical Recent Developments/Updates
Table 103. Eurocor Tech GmbH Corporation Information
Table 104. Eurocor Tech GmbH Description and Business Overview
Table 105. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product
Table 107. Eurocor Tech GmbH Recent Developments/Updates
Table 108. OrbusNeich Corporation Information
Table 109. OrbusNeich Description and Business Overview
Table 110. OrbusNeich Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. OrbusNeich Coronary Intervention Drug Eluting Stent Product
Table 112. OrbusNeich Recent Developments/Updates
Table 113. Endocor GmbH Corporation Information
Table 114. Endocor GmbH Description and Business Overview
Table 115. Endocor GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Endocor GmbH Coronary Intervention Drug Eluting Stent Product
Table 117. Endocor GmbH Recent Developments/Updates
Table 118. Meril Life Sciences Corporation Information
Table 119. Meril Life Sciences Description and Business Overview
Table 120. Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Meril Life Sciences Coronary Intervention Drug Eluting Stent Product
Table 122. Meril Life Sciences Recent Developments/Updates
Table 123. Acrostak Corporation Information
Table 124. Acrostak Description and Business Overview
Table 125. Acrostak Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Acrostak Coronary Intervention Drug Eluting Stent Product
Table 127. Acrostak Recent Developments/Updates
Table 128. Boston Scientific Corporation Corporation Information
Table 129. Boston Scientific Corporation Description and Business Overview
Table 130. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product
Table 132. Boston Scientific Corporation Recent Developments/Updates
Table 133. B. Braun Corporation Information
Table 134. B. Braun Description and Business Overview
Table 135. B. Braun Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. B. Braun Coronary Intervention Drug Eluting Stent Product
Table 137. B. Braun Recent Developments/Updates
Table 138. Biotronik Corporation Information
Table 139. Biotronik Description and Business Overview
Table 140. Biotronik Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Biotronik Coronary Intervention Drug Eluting Stent Product
Table 142. Biotronik Recent Developments/Updates
Table 143. Abbott Corporation Information
Table 144. Abbott Description and Business Overview
Table 145. Abbott Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Abbott Coronary Intervention Drug Eluting Stent Product
Table 147. Abbott Recent Developments/Updates
Table 148. MicroPort Medical Group Corporation Information
Table 149. MicroPort Medical Group Description and Business Overview
Table 150. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product
Table 152. MicroPort Medical Group Recent Developments/Updates
Table 153. Philips Corporation Information
Table 154. Philips Description and Business Overview
Table 155. Philips Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Philips Coronary Intervention Drug Eluting Stent Product
Table 157. Philips Recent Developments/Updates
Table 158. Terumo Corporation Corporation Information
Table 159. Terumo Corporation Description and Business Overview
Table 160. Terumo Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Terumo Corporation Coronary Intervention Drug Eluting Stent Product
Table 162. Terumo Corporation Recent Developments/Updates
Table 163. Production Base and Market Concentration Rate of Raw Material
Table 164. Key Suppliers of Raw Materials
Table 165. Coronary Intervention Drug Eluting Stent Distributors List
Table 166. Coronary Intervention Drug Eluting Stent Customers List
Table 167. Coronary Intervention Drug Eluting Stent Market Trends
Table 168. Coronary Intervention Drug Eluting Stent Growth Drivers
Table 169. Coronary Intervention Drug Eluting Stent Market Restraints
Table 170. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Type (2022-2027) & (K Units)
Table 171. Global Coronary Intervention Drug Eluting Stent Sales Market Share Forecast by Type (2022-2027)
Table 172. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 173. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Type (2022-2027)
Table 174. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Application (2022-2027) & (K Units)
Table 175. Global Coronary Intervention Drug Eluting Stent Sales Market Share Forecast by Application (2022-2027)
Table 176. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 177. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Application (2022-2027)
Table 178. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Region (2022-2027) & (K Units)
Table 179. Global Coronary Intervention Drug Eluting Stent Sales Market Share Forecast by Region (2022-2027)
Table 180. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 181. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Region (2022-2027)
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Coronary Intervention Drug Eluting Stent
Figure 2. Global Coronary Intervention Drug Eluting Stent Market Share by Type in 2020 & 2027
Figure 3. Below 40 µm Product Picture
Figure 4. 40 µm- 65 µm Product Picture
Figure 5. Above 65 µm Product Picture
Figure 6. Global Coronary Intervention Drug Eluting Stent Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Global Coronary Intervention Drug Eluting Stent Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Coronary Intervention Drug Eluting Stent Market Size 2016-2027 (US$ Million)
Figure 12. Global Coronary Intervention Drug Eluting Stent Sales 2016-2027 (K Units)
Figure 13. Global Coronary Intervention Drug Eluting Stent Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Coronary Intervention Drug Eluting Stent Sales Share by Manufacturers in 2020
Figure 15. Global Coronary Intervention Drug Eluting Stent Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Coronary Intervention Drug Eluting Stent Players: Market Share by Revenue in 2020
Figure 17. Coronary Intervention Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2016-2021)
Figure 19. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Region in 2020
Figure 20. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Region (2016-2021)
Figure 21. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Region in 2020
Figure 22. U.S. Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Coronary Intervention Drug Eluting Stent Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Coronary Intervention Drug Eluting Stent by Type (2016-2021)
Figure 47. Sales Market Share of Coronary Intervention Drug Eluting Stent by Application (2016-2021)
Figure 48. Sales Market Share of Coronary Intervention Drug Eluting Stent by Application in 2020
Figure 49. Revenue Share of Coronary Intervention Drug Eluting Stent by Application (2016-2021)
Figure 50. Revenue Share of Coronary Intervention Drug Eluting Stent by Application in 2020
Figure 51. Manufacturing Cost Structure of Coronary Intervention Drug Eluting Stent
Figure 52. Manufacturing Process Analysis of Coronary Intervention Drug Eluting Stent
Figure 53. Coronary Intervention Drug Eluting Stent Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed